woman doing research while holding equipmentPhoto by National Cancer Institute
What experts had to say about Keytruda at ESMO 2024.
  • FDA approves Merck’s KEYTRUDA with Pemetrexed and Platinum Chemotherapy for first-line treatment of advanced or metastatic malignant pleural mesothelioma.

Wed Sep 18 09:02:10 – 2024 UTC– Merck in New Jersey announced FDA approval for KEYTRUDA® plus chemotherapy for mesothelioma treatment.

Nobot.News is not a bot, but powered by generative AI.

Check Lisa out now:
https://nobot.news/about-nobot-news/

Subscribe to Lisa’s Newsletter today!

Keep Up: Nobot.News Launches Breaking Newsletter

Read more Business News as it happens!

Business

Another FDA approval from the same dasy by AstraZenca.

By Lisa Luckas

Lisa Luckas is a Sr. Business News Editor at Nobot.News.

Leave a Reply

Your email address will not be published. Required fields are marked *

GDPR Cookie Consent with Real Cookie Banner